Phospholipid transverse mobility modifications in plasma membranes of activated platelets: an ESR study

Biochem Biophys Res Commun. 1992 Nov 30;189(1):465-71. doi: 10.1016/0006-291x(92)91581-a.

Abstract

Spin labeled phospholipid analogs were used to directly study changes in aminophospholipid translocase activity in activated platelets. In thrombin-activated platelets, the translocase activity was slightly stimulated, whereas no vesicle formation or proteolysis of cytoskeletal protein occurred. Ca2+ ionophore A23187-mediated activation produced vesiculation and proteolysis. Additionally, the translocase activity was completely inhibited, probably due to a sharp rise the intracellular Ca2+ concentration, as shown when platelets were activated in the presence of various A23187 and Ca2+ concentrations and by the recovery of the translocase activity when Ca2+ was complexed with EGTA. No translocase activity was found in vesicles. Whereas vesiculation and translocase inhibition can occur independently of proteolysis, this later accentuated the shedding phenomenon.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blood Platelets / drug effects
  • Blood Platelets / metabolism*
  • Calcimycin / pharmacology
  • Calcium / pharmacology
  • Cell Membrane / drug effects
  • Cell Membrane / metabolism*
  • Egtazic Acid / pharmacology
  • Electron Spin Resonance Spectroscopy
  • Humans
  • In Vitro Techniques
  • Kinetics
  • Phospholipids / blood*
  • Platelet Activation* / drug effects
  • Spin Labels
  • Thrombin / pharmacology

Substances

  • Phospholipids
  • Spin Labels
  • Calcimycin
  • Egtazic Acid
  • Thrombin
  • Calcium